In our study of 1298 patients, the nomogram accurately predicted low-risk results for most individuals but underestimated risk in some patients with aggressive tumor features, such as high tumor grade, lack of progesterone receptor expression, and high Ki-67 levels. The gene discussed is PGR; the disease is neoplasm.